A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Trial Profile

A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Pentylenetetrazole (Primary)
  • Indications Hypersomnia; Narcolepsy
  • Focus Therapeutic Use
  • Sponsors Balance Therapeutics
  • Most Recent Events

    • 27 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
    • 27 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 08 Oct 2015 Status changed from not yet recruiting to recruiting as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top